Find the latest science, technology and partners in antibody engineering, immunobiology and next generation binders.

Podcast: How to Create the Ultimate Bispecific

Share this article

What does it take to create the perfect bispecific?

That's what we asked Volker Schellenberger, President and Chief Technology Officer at Amunix Pharmaceuticals in a very first episode of the Life Sciences podcast.

As co-founder of Amunix, Schellenberger is the lead inventor of the company’s XTEN as well as XPAT platforms of protease-activated T-cell engagers. In conversation with Conference Producer Eden Turner, he discussed the key steps to producing the ultimate bispecific, including the most important considerations for designing a platform and notable trends in antibody engineering techniques.

Listen to the full podcast episode below or click here to listen on Soundcloud.

Share this article

Upcoming event

Antibody Engineering & Therapeutics Asia

24 - 26 Feb 2021, Kyoto, Japan
THE ONLY EVENT IN ASIA PROVIDING THE LATEST SCIENCE, TECHNOLOGY AND PARTNERS TO ACCELERATE ANTIBODY & PROTEIN THERAPIES, ADCS, BISPECIFICS AND IMMUNO-ONCOLOGY
Go to site